Evidence map›Paper›PMID 34857004›Full record

ReviewPediatric rheumatology online journal2021

Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East.

Sulaiman M Al-Mayouf, Muna Al Mutairi, Kenza Bouayed, Sara Habjoka, Djohra Hadef, Hala M Lotfy, Cristiaan Scott, Elsadeg M Sharif, Nouran Tahoun

Open access · goldAbstract readReview
In one paragraph

Review in Pediatric rheumatology online journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 6 countries.

Sulaiman M Al-MayoufPediatric Rheumatology, King Faisal Specialist Hospital and Research Center College of Medicine, Alfaisal University, Po Box 3354, Riyadh, 11211, Saudi Arabia. mayouf@kfshrc.edu.sa.ORCID http://orcid.org/0000-0003-0142-6698
Muna Al MutairiAl Adan Hospital, Hadiya, State of Kuwait.
Kenza BouayedDepartment of Rheumatology and Pediatric Internal Medicine, University Hospital IBN Rochd, Casablanca, Morocco.
Sara HabjokaPfizer Biopharmaceutical Group, Emerging Markets, Dubai, United Arab Emirates.
Djohra HadefDepartment of Pediatrics, University Hospital Center of Batna Faculty of Medicine, Batna 2 University, Batna, Algeria.
Hala M LotfyProfessor of Pediatrics and Pediatric Rheumatology, Cairo University, Giza, Egypt.
Cristiaan ScottDivision of Paediatric Rheumatology, Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.
Elsadeg M SharifConsultant Rheumatologist, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.
Nouran TahounPfizer Biopharmaceutical Group, Emerging Markets, Cairo, Egypt.
Adan Hospital · KWAlfaisal University · SACairo University · EGCentre Hospitalier Universitaire Ibn Rochd · MAUniversity of Batna 1 · DZUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juvenile Idiopathic Arthritis (JIA) is a group of chronic heterogenous disorders that manifests as joint inflammation in patients aged <16 years. Globally, approximately 3 million children and young adults are suffering from JIA with prevalence rates consistently higher in girls. The region of Africa and Middle East constitute a diverse group of ethnicities, socioeconomic conditions, and climates which influence the prevalence of JIA. There are only a few studies published on epidemiology of JIA in the region. There is an evident paucity of adequate and latest data from the region. This review summarizes the available data on the prevalence of JIA and its subtypes in Africa and Middle East and discusses unmet needs for patients in this region. A total of 8 journal publications were identified concerning epidemiology and 42 articles describing JIA subtypes from Africa and Middle East were included. The prevalence of JIA in Africa and Middle East was observed to be towards the lower range of the global estimate. We observed that the most prevalent subtype in the region was oligoarticular arthritis. The incidence of uveitis and anti-nuclear antibody (ANA) positivity were found to be lower as compared to the incidence from other regions. There is a huge unmet medical need in the region for reliable epidemiological data, disease awareness, having regional and local treatment guidelines and timely diagnosis. Paucity of the pediatric rheumatologists and economic disparities also contribute to the challenges regarding the management of JIA.

Indexed as

AdolescentAfricaArthritis, JuvenileChildChild, PreschoolFemaleHumansIncidenceInfantInfant, NewbornMaleMiddle EastPrevalence

Identifiers

PMID34857004
PMCPMC8638433
OpenAlexW3214761571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.